Loading...
Welcia Holdings Co., Ltd.
WLCGF•PNK
Healthcare
Medical - Pharmaceuticals
$16.41
$0.00(0.00%)
Welcia Holdings Co., Ltd. (WLCGF) Financial Performance & Income Statement Overview
Review Welcia Holdings Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.56%
↑ 5.56%
Operating Income Growth
-15.78%
↓ 15.78%
Net Income Growth
-43.45%
↓ 43.45%
Operating Cash Flow Growth
2.83%
↑ 2.83%
Operating Margin
2.83%
↑ 2.83%
Gross Margin
30.32%
↑ 30.32%
Net Profit Margin
1.16%
↑ 1.16%
ROE
6.09%
↑ 6.09%
ROIC
10.60%
↑ 10.60%
Welcia Holdings Co., Ltd. (WLCGF) Income Statement & Financial Overview
Review Welcia Holdings Co., Ltd.'s (WLCGF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $333.09B | $321.33B | $325.85B | $304.73B |
| Cost of Revenue | $235.39B | $226.01B | $225.22B | $216.53B |
| Gross Profit | $97.70B | $95.32B | $100.64B | $88.20B |
| Gross Profit Ratio | $0.29 | $0.30 | $0.31 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $84.15B | $91.38B | $87.25B | $82.71B |
| Operating Expenses | $84.15B | $91.34B | $87.25B | $82.71B |
| Total Costs & Expenses | $319.54B | $317.36B | $312.47B | $299.24B |
| Interest Income | $10.00M | $0.00 | $9.00M | $3.00M |
| Interest Expense | $205.00M | $0.00 | $191.00M | $184.00M |
| Depreciation & Amortization | $7.69B | $6.10B | $6.18B | $5.94B |
| EBITDA | $8.59B | $10.04B | $20.54B | $12.60B |
| EBITDA Ratio | $0.03 | $0.03 | $0.06 | $0.04 |
| Operating Income | $13.55B | $3.97B | $13.38B | $5.50B |
| Operating Income Ratio | $0.04 | $0.01 | $0.04 | $0.02 |
| Other Income/Expenses (Net) | -$12.83B | $936.00M | $786.00M | $976.00M |
| Income Before Tax | $722.00M | $4.91B | $14.17B | $6.47B |
| Income Before Tax Ratio | $0.002 | $0.02 | $0.04 | $0.02 |
| Income Tax Expense | $738.00M | $2.06B | $5.30B | $3.84B |
| Net Income | $179.00M | $3.06B | $8.89B | $2.82B |
| Net Income Ratio | $0.001 | $0.010 | $0.03 | $0.009 |
| EPS | $0.83 | $14.76 | $42.92 | $13.67 |
| Diluted EPS | $0.83 | $14.77 | $42.95 | $13.66 |
| Weighted Avg Shares Outstanding | $216.92M | $207.39M | $207.17M | $206.66M |
| Weighted Avg Shares Outstanding (Diluted) | $216.92M | $207.31M | $207.05M | $206.79M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan